angiotensing converting enzyme inhibitors, enalapril
DISEASE INTERVENTION COMPARISON RESULTS
Circulation. 2003 Jun 17;107(23):2926-31 Randomized Controlled Trial
IN StudyID: Vermes 2003, atrial fibrillation, heart failure The Use of
angiotensing converting enzyme inhibitors, enalapril
As Treatment, Chronic
Is better Than
placebo
To reducing the risk of development of atrial fibrillation in patients with left ventricular dysfunction (at 3 years: 5,4% ACEi vs 24% placebo)